Disease
4 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 11, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 registry record with completed enrollment but no results posted; insufficient to assess efficacy or safety, only study design and conduct are known.
SEP 9, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a clinical trial registry record describing a planned observational study with no results posted; it documents study design and intended outcomes only, not evidence of efficacy or safety.
AUG 24, 2026 · JOURNAL ARTICLE
Renal Failure
Cross-sectional study with sound methodology in a defined population showing clear associations between anthropometric measures and sarcopenia in older adults with CKD, but limited by observational design and lack of temporal or causal inference.
APR 7, 2026 · JOURNAL ARTICLE
Renal Failure
This is a bibliometric analysis of published literature, not a primary clinical study, and provides no original outcome data on sacubitril/valsartan efficacy or safety.